Kymera Therapeutics, Inc 10-Q for FY2025 Q3
Kymera Therapeutics, Inc. (KYMR)
10-Q
2025-11-04
For: 2025-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Kymera Therapeutics, Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.76M
- down 26.1% from $3.74M a year earlier
- Net loss
- $82.18M
- compared with a net loss of $62.49M a year earlier
- Diluted EPS
- -$0.94
- compared with -$0.82 a year earlier